Skip to main content
. 2020 Jun 1;108(1):427–437. doi: 10.1002/JLB.5MIR0420-055R

FIGURE 2.

FIGURE 2

Overview of recent clinical studies using IL‐2 alone or in combination with other drugs in the therapy against cancer, autoimmune disorders, graft‐versus‐host disease, or infection